Skip to main content

Advertisement

ADVERTISEMENT

News

News
05/15/2019
The device and new delivery system combine proven conformability with enhanced placement control to optimize TEVAR outcomes in even complex aortic anatomy
The device and new delivery system combine proven conformability with enhanced placement control to optimize TEVAR outcomes in even complex aortic anatomy
The device and new delivery...
05/15/2019
Vascular Disease Management

Advertisement

News
05/01/2019
Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ZOOM™ Aspiration System.
Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ZOOM™ Aspiration System.
Imperative Care, Inc. today...
05/01/2019
Vascular Disease Management
News
05/01/2019
The Zenith T-graft is a safe and relatively straightforward alternative to custom-made endografts for thoracoabdominal aortic aneurysms, which can take up to eight weeks to manufacture. For emergency cases, it can save lives.  London, UK, 17...
The Zenith T-graft is a safe and relatively straightforward alternative to custom-made endografts for thoracoabdominal aortic aneurysms, which can take up to eight weeks to manufacture. For emergency cases, it can save lives.  London, UK, 17...
The Zenith T-graft is a safe and...
05/01/2019
Vascular Disease Management
News
04/23/2019
 Two-year results reveal that the BioMimics 3D Stent is as effective as drug-coated balloon (DCB) and drug-eluting stent (DES) competitors, even in a patient group that includes more challenging cases.  London, UK, Thursday 18 April 2019 –...
 Two-year results reveal that the BioMimics 3D Stent is as effective as drug-coated balloon (DCB) and drug-eluting stent (DES) competitors, even in a patient group that includes more challenging cases.  London, UK, Thursday 18 April 2019 –...
 Two-year results reveal that...
04/23/2019
Vascular Disease Management

Advertisement

News
04/23/2019
 London, UK, 16 April 2019 – A “superglue” treatment for varicose veins remains effective in 94.6% of patients five years after the procedure, according to new data presented at the Charing Cross Symposium 2019 on Tuesday 16 April. 
 London, UK, 16 April 2019 – A “superglue” treatment for varicose veins remains effective in 94.6% of patients five years after the procedure, according to new data presented at the Charing Cross Symposium 2019 on Tuesday 16 April. 
 London, UK, 16 April 2019 – A...
04/23/2019
Vascular Disease Management
News
04/23/2019
The Lutonix DCB is safe to use and effective in patients with narrowed or obstructed arteries below the knee – even more complex ones with minor tissue loss, according to data presented at the Charing Cross Symposium 2019 on Thursday 18...
The Lutonix DCB is safe to use and effective in patients with narrowed or obstructed arteries below the knee – even more complex ones with minor tissue loss, according to data presented at the Charing Cross Symposium 2019 on Thursday 18...
The Lutonix DCB is safe to use...
04/23/2019
Vascular Disease Management
News
04/18/2019
BUELACH, Switzerland and LONDON, UK, April 18, 2019 – BIOLUX P-III 24-month study data supports safe and effective clinical performance of the Passeo®-18 LuxTM drug-coated balloon (DCB) for patients with infrapopliteal artery lesions and...
BUELACH, Switzerland and LONDON, UK, April 18, 2019 – BIOLUX P-III 24-month study data supports safe and effective clinical performance of the Passeo®-18 LuxTM drug-coated balloon (DCB) for patients with infrapopliteal artery lesions and...
BUELACH, Switzerland and LONDON,...
04/18/2019
Vascular Disease Management

Advertisement

News
04/17/2019
Medtronic plc (NYSE:MDT) today announced five-year outcomes from the VeClose Extension Study. Nick Morrison, M.D., Center for Vein Restoration, Mesa, Ariz., presented at the 2019 Charing Cross Symposium in London. The new data demonstrate...
Medtronic plc (NYSE:MDT) today announced five-year outcomes from the VeClose Extension Study. Nick Morrison, M.D., Center for Vein Restoration, Mesa, Ariz., presented at the 2019 Charing Cross Symposium in London. The new data demonstrate...
Medtronic plc (NYSE:MDT) today...
04/17/2019
Vascular Disease Management
News
04/15/2019
First-of-its-Kind Treatment for Post-Angioplasty Above-the-Knee Dissections Now Available April 15, 2019 07:00 AM Eastern Daylight Time
First-of-its-Kind Treatment for Post-Angioplasty Above-the-Knee Dissections Now Available April 15, 2019 07:00 AM Eastern Daylight Time
First-of-its-Kind Treatment for...
04/15/2019
Vascular Disease Management
News
04/10/2019
The ongoing controversy about paclitaxel-eluting devices was discussed at the Society of Interventional Radiology meeting in Austin, Texas.
The ongoing controversy about paclitaxel-eluting devices was discussed at the Society of Interventional Radiology meeting in Austin, Texas.
The ongoing controversy about...
04/10/2019
Vascular Disease Management

Advertisement

Advertisement